The revolutionary impact of immune checkpoint inhibitors (ICIs) has transformed cancer care, yielding unprecedented durable responses across a spectru
Read Full Article To Earn PointsDaily news to keep you up to date
Participate and win exciting prizes
Participate and win cash vouchers
Get updates on the latest events happening around the world
1.
When BCG is not effective in treating bladder cancer, Oncolytic Virus exhibits high response rates.
2.
Even after a partial ban, asbestos is still used and is a deadly carcinogen, according to the EPA.
3.
Immunotherapy Is As Safe As Other Cancer Treatments During Pregnancy.
4.
Novel Psychedelic Promising on Resistant Depression
5.
Thriving while surviving: Understanding the social needs of cancer survivors
1.
Is p53 the Missing Puzzle Piece? Exploring Its Polymorphisms in Cervical Cancer Risk
2.
Unraveling the Mysteries of Metastasis: Exploring the Latest Advances in Cancer Research
3.
Decoding Efficacy, Safety, and Future Frontiers in CAR-T Cell Therapy for Hematologic Malignancies Towards CAR-T Therapy 2025
4.
What is Hemorrhagic Cystitis and How to Manage its Symptoms
5.
Beyond the Biopsy: The Evolving Landscape of Prostate Cancer Management
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
2.
Navigating the Complexities of Ph Negative ALL - Part IX
3.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation